Displaying drugs 926 - 950 of 2780 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Oteracil | 157.0843 C4H3N3O4 |  | A chemotherapy agent used in combination with tegafur, cisplatin and gimeracil to treat advanced gastric cancer. | Triazines |
| Ospemifene | 378.891 C24H23ClO2 |  | A non-hormonal estrogen receptor modulator (SERM) used to treat moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. | Selective Estrogen Receptor Modulators |
| Osimertinib | 499.619 C28H33N7O2 |  | A tyrosine kinase inhibitor used in the treatment of certain types of non-small cell lung carcinoma. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Osilodrostat | 227.242 C13H10FN3 |  | An oral inhibitor of cortisol synthesis used to treat Cushing's disease by normalizing hypercortisolism. | Anticorticosteroids |
| Oseltamivir | 312.4045 C16H28N2O4 |  | A neuraminidase inhibitor used in the prophylaxis and treatment of influenza. | Acetamides / Antiviral Agents / Neuraminidase Inhibitors |
| Orphenadrine | 269.3813 C18H23NO |  | A muscarinic antagonist used as an adjunct for the symptomatic relief of musculoskeletal pain and discomfort. | Ethers, Chemically Close to Antihistamines |
| Ornithine | 132.161 C5H12N2O2 |  | An amino acid commonly found as a component in total parenteral nutrition. | Liver Therapy |
| Orlistat | 495.7348 C29H53NO5 |  | A reversible inhibitor of gastrointestinal lipases indicated for weight loss and weight maintenance. | Peripherally Acting Antiobesity Products |
| Oritavancin | 1793.101 C86H97Cl3N10O26 |  | An antibacterial agent used to treat acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria. | Glycopeptide Antibacterials |
| Orciprenaline | 211.2576 C11H17NO3 |  | A beta-2 adrenergic agonist used to treat bronchospasm, asthma, and COPD. | Non-selective Beta-adrenergic Agonists |
| Opium | Not Available |  | A medication used to treat moderate to severe pain. | Natural Opium Alkaloids |
| Opicapone | 413.17 C15H10Cl2N4O6 |  | A catechol-O-methyltransferase inhibitor used as an adjunct treatment for Parkinson's Disease in adults currently receiving levodopa and a dopa decarboxylase inhibitor. | COMT Inhibitors |
| Ondansetron | 293.363 C18H19N3O |  | A serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting in cancer chemotherapy and postoperatively. | Anti-Anxiety Agents / Antiemetics / Carbazoles / Imidazoles / Serotonin 5-HT3 Receptor Antagonists / Serotonin Receptor Antagonists |
| Omidenepag isopropyl | 520.61 C26H28N6O4S |  | An agonist of the prostaglandin EP2 receptor indicated for the reduction of elevated intraocular pressure. | Antiglaucoma Agents / Hypotensive Agents / Ophthalmic Solutions / Ophthalmics / Prodrugs / Pyrazoles / Pyridines / Receptors, Prostaglandin E, EP2 Subtype, agonists / Sulfonamides |
| Omeprazole | 345.416 C17H19N3O3S |  | A proton pump inhibitor used to treat GERD associated conditions such as heartburn and gastric acid hypersecretion, and to promote healing of tissue damage and ulcers caused by gastric acid and H. pylori infection. | 2-Pyridinylmethylsulfinylbenzimidazoles / Anti-Ulcer Agents / Proton Pump Inhibitors |
| Omega-3-carboxylic acids | Not Available |  | A medication used with other medications to lower triglyceride levels in adult patients with severe hypertriglyceridemia. | Fatty Acids, Omega-3 |
| Omega-3-acid ethyl esters | Not Available |  | A mixture of fatty acids used as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia. | Fatty Acids, Omega-3 / Nootropic Agents |
| Omega-3 fatty acids | Not Available |  | An ingredient found in a variety of supplements and vitamins. | Liver Therapy |
| Ombitasvir | 894.127 C50H67N7O8 |  | A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections. | Antivirals for treatment of HCV infections |
| Omaveloxolone | 554.723 C33H44F2N2O3 |  | A semisynthetic triterpenoid used to treat Friedreich’s ataxia in adults and adolescents 16 years and older. | Anti-Inflammatory Agents / Antioxidants / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / OAT1/SLC22A6 inhibitors / Oxidation-Reduction Agent / Terpenes / Triterpenes |
| Omadacycline | 556.66 C29H40N4O7 |  | A tetracycline antibiotic used to treat community acquired bacterial pneumonia. | Tetracyclines |
| Omacetaxine mepesuccinate | 545.6213 C29H39NO9 |  | A cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors. | Antineoplastic Agents |
| Olutasidenib | 354.79 C18H15ClN4O2 |  | An isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation as detected by an FDA-approved test. | Antineoplastic Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Enzyme Inhibitors / Heterocyclic Compounds, Fused-Ring / Isocitrate dehydrogenase-1 (IDH1) inhibitors / Isocitrate Dehydrogenase-1 Inhibitors / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / Potential QTc-Prolonging Agents / QTc Prolonging Agents |
| Olsalazine | 302.239 C14H10N2O6 |  | An anti-inflammatory aminosalicylate used in the treatment of inflammatory bowel disease and ulcerative colitis. | Salicylates |
| Olopatadine | 337.4122 C21H23NO3 |  | A histamine H1 antagonist used to treat allergic conjunctivitis and rhinitis. | Antiallergic Agents, Excl. Corticosteroids |
Displaying drugs 926 - 950 of 2780 in total